Ingevity (NYSE:NGVT) Posts Earnings Results, Beats Expectations By $0.41 EPS

Ingevity (NYSE:NGVTGet Free Report) posted its quarterly earnings data on Wednesday. The company reported $1.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.41, FiscalAI reports. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company had revenue of $314.10 million during the quarter, compared to analyst estimates of $312.20 million. Ingevity updated its FY 2026 guidance to 5.000-5.450 EPS.

Ingevity Price Performance

Shares of NYSE NGVT traded down $1.34 during trading hours on Thursday, reaching $69.28. 190,545 shares of the stock traded hands, compared to its average volume of 293,758. The company’s 50-day simple moving average is $71.53 and its two-hundred day simple moving average is $70.91. The company has a market capitalization of $2.41 billion, a P/E ratio of -19.40 and a beta of 1.16. Ingevity has a 52-week low of $39.74 and a 52-week high of $79.29. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83.

Insider Transactions at Ingevity

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares in the company, valued at $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.88% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Ingevity

Large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC increased its holdings in shares of Ingevity by 10.9% in the first quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after buying an additional 1,323 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Ingevity by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock worth $863,000 after acquiring an additional 1,080 shares during the last quarter. Empowered Funds LLC increased its stake in Ingevity by 12.9% in the 1st quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock worth $205,000 after purchasing an additional 594 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after purchasing an additional 454,579 shares during the last quarter. Finally, Jane Street Group LLC boosted its stake in shares of Ingevity by 306.1% during the first quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock valued at $3,519,000 after purchasing an additional 66,995 shares during the period. Hedge funds and other institutional investors own 91.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on NGVT. Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a report on Friday, July 17th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $80.00.

Check Out Our Latest Stock Report on NGVT

Ingevity Company Profile

(Get Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Featured Stories

Earnings History for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.